Novo Nordisk (NVO) announced Friday that the U.S. Food and Drug Administration (FDA) accepted its marketing application for ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Insurers reported 91 per cent increase in claims for weight-loss drugs last year after Wegovy launched in Canada ...

Since Wegovy is prescribed in higher doses, it can be more effective than Ozempic for weight loss. A 2022 systematic review and meta-analysis looked at eight studies with more than 4,500 participants.

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

A healthcare professional will review your visit and schedule an in-depth consultation to determine eligibility. If Wegovy or another weight loss medication is appropriate, Ro will connect you ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

The weight loss drug Wegovy treated a serious form of liver ... The FDA has granted the drug a priority review designation, the drugmaker said, meaning it will review the application in six ...